Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
pregnancy specific beta-1-glycoprotein 11 | 1.000 | 0.038 | 4.8E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
SLC2A4 regulator | 0.615 | 0.692 | 0.22 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1 | 0.716 | 0.423 | 9.3E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
vertebrae development associated | 1.000 | 0.077 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ankyrin repeat and SOCS box containing 1 | 0.890 | 0.077 | 3.0E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
serpin family A member 10 | 0.805 | 0.192 | 4.2E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
deleted in esophageal cancer 1 | 0.573 | 0.692 | 2.7E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
isovaleryl-CoA dehydrogenase | 0.705 | 0.462 | 1.5E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
integrin subunit alpha X | 0.504 | 0.769 | 1.4E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
integrin subunit alpha 1 | 0.644 | 0.654 | 2.6E-16 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2019 | ||||||||
|
bone morphogenetic protein 8a | 0.839 | 0.154 | 2.0E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
eyes shut homolog | 0.631 | 0.538 | 3.7E-41 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
homeobox A3 | 0.695 | 0.538 | 0.94 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
tetratricopeptide repeat domain 6 | 0.931 | 0.154 | 1.1E-25 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
major histocompatibility complex, class I, K (pseudogene) |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
PYD and CARD domain containing | 0.457 | 0.808 | 2.0E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
ERCC excision repair 6 like 2 | 0.729 | 0.346 | 5.1E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ADP ribosylation factor like GTPase 15 | 0.769 | 0.346 | 9.4E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
homeobox A5 | 0.595 | 0.577 | 3.0E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
methylthioadenosine phosphorylase | 0.514 | 0.731 | 7.6E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
SUZ12 pseudogene 1 | 0.890 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
ataxin 3 | 0.521 | 0.808 | 0.11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
MHC class I polypeptide-related sequence B | 0.576 | 0.731 | 4.1E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 |